Divestitures (Details) - USD ($) $ in Millions	Nov. 29, 2022	Sep. 30, 2023	Dec. 31, 2022
Assets held for sale
Total assets held for sale		$ 427.3	$ 230.3
Liabilities held for sale
Total liabilities held for sale		14.3	0.0
Disposal Group, Held-for-Sale, Not Discontinued Operations
Assets held for sale
Accounts receivable, net		34.5	0.0
Inventories		40.0	0.0
Prepaid expenses and other current assets		0.7	0.0
Property, plant and equipment, net		26.3	0.0
Intangible assets, net		259.7	230.3
Goodwill		65.9	0.0
Other assets		0.2	0.0
Liabilities held for sale
Accounts payable		8.4	0.0
Other current liabilities		5.5	0.0
Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent		$ 0.4
Other long-term obligations			$ 0.0
Biocon Biologics | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Liabilities held for sale
Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term	2 years